X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
NATCO PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 115.2%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on 19th April, 2019 on account of Good Friday.

NATCO PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 115.2%
Mon, 12 Nov

NATCO PHARMA has announced its results for the quarter ended September 2018. Here is a detailed performance review of the same:

NATCO PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Sep-17*
3
Jun-18*
3
Sep-18*
QoQ ChangeYoY Change
Net SalesRs m4,2675,3865,4350.9%27.4%
Other incomeRs m5535940011.4%627.3%
TurnoverRs m4,3225,7455,8351.6%35.0%
ExpensesRs m3,0483,2103,2300.6%6.0%
Gross profitRs m1,2192,1762,2051.3%80.9%
DepreciationRs m1601842029.8%26.3%
InterestRs m42285078.6%19.0%
Profit before taxRs m1,0722,3232,3531.3%119.5%
TaxRs m2285125374.9%135.5%
Profit after taxRs m8441,8111,8160.3%115.2%
Gross profit margin%28.640.440.6
Effective tax rate%21.322.022.8
Net profit margin%19.531.531.1
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 27.4% on a year-on-year (YoY) basis. The expenses were up by 6.0% YoY during the same period.
  • The company's operating profit increased by 80.9% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 40.6% in 2QFY19 as against 28.6% in 2QFY18.
  • Depreciation charges increased by 26.3% and finance costs increased by 19.0% YoY, respectively.
  • Other income increased by 627.3% YoY during the quarter.
  • Net profit for the quarter increased by 115.2% YoY. Net profit margins during the quarter increased from 19.5% in 2QFY18 to 31.1% in 2QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 0.9% on a quarter-on-quarter (QoQ) basis. The expenses were up by 0.6% QoQ during the same period.
  • The company's operating profit increased by 1.3% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 40.6% in 2QFY19 as against 40.4% in 1QFY18.
  • Net profit for the quarter increased by 0.3% QoQ, while net profit margins declined from 31.5% in 1QFY18 to 31.1% in 2QFY19.

To see how NATCO PHARMA has performed over the last eight quarters, please visit here.

NATCO PHARMA Share Price Performance

Over the last one year, NATCO PHARMA share price has moved up from Rs 913.3 to Rs 752.7, registering a Loss of Rs 160.6 or around 17.6%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 14,701.3 (up 0.1%). Over the last one year it has moved up from 13,858.9 to 14,701.3, a gain of 842 points (up 6.1%).

Overall, the S&P BSE SENSEX is up 5.7% over the year.

Current Valuations

At the current price of Rs 752.7, the price to earnings (P/E) ratio of NATCO PHARMA stands at 14.2 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 4.1 times.

Equitymaster requests your view! Post a comment on "NATCO PHARMA Announces Quarterly Results (2QFY19); Net Profit Up 115.2%". Click here!

  

Related Views on News

NATCO PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 26.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (down 26.7% YoY). Sales on the other hand came in at Rs 6 bn (down 1.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 93.3% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (up 93.3% YoY). Sales on the other hand came in at Rs 5 bn (up 21.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

NATCO PHARMA SHARE PRICE


Apr 18, 2019 (Close)

TRACK NATCO PHARMA

  • Track your investment in NATCO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NATCO PHARMA - WOCKHARDT COMPARISON

COMPARE NATCO PHARMA WITH

MARKET STATS